Allergen immunotherapy: does it work and, if so, how and for how long?

By D. S. Robinson. Thorax, 2000

1,111 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis (2018, background): “Grass pollen SCIT for 3-4 years has been shown to result in long-term efficacy for 3 years after discontinuation.(83) In a recent study, either SCIT or SLIT tablets were effective compared to placebo over 2 years, but 2 years were insufficient for long-term efficacy as measured 1 year off treatment.”
The diagnosis and management of rhinitis: an updated practice parameter. (2008, background): “Immunotherapy has been associated with significant improvement in rhinitis symptom and medication scores and QOL measures as well as objective parameters such as nasal provocation challenge.(466,471,479,482-518) Immunotherapy is usually no more costly than pharmacotherapy over the projected course o”
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report (2007, background): “The effect of immunotherapy appears to continue after treatment has stopped, resulting in prolonged clinical remission of allergic rhinitis symptoms (235).”
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis * (2005, background): “excluded [not randomized/controlled (4), insufficient information for analysis (3), duplicate study (1)] and three remain pending – awaiting additional information or data from authors.”